In obese women with PCOS, GCs also exhibit reduced FSH receptor expression, a defect consistent with the clinical requirement of higher total doses and/or prolonged administration of FSH during controlled ovarian IVF protocols [126], as observed for obese patients [13,17]. Here, BRD2 is linked to polycystic ovary syndrome.